Insights · Life Sciences

Life Sciences — Insights

In-depth analysis of how ColdAI's strategic intelligence, AI systems and distributed ledger infrastructure are transforming the Life Sciences sector. Authored by Dr. Shayan Salehi H.C.

All insightsIndustry overview
Why Drug Developers Are Abandoning Centralized Data Lakes for Federated Ledgers — life-sciences
Life Sciences

Inside: Drug Developers Are Abandoning Centralized Data Lakes for Federated Ledgers

Pharmaceutical companies now lose less IP to distributed compute than to cloud breaches, reversing two decades of centralization economics.

·8 min read
Why Phase II Trials Now Cost Less Than Phase I Infrastructure — life-sciences
Life Sciences

The case for: Phase II Trials Now Cost Less Than Phase I Infrastructure

Agentic clinical trial orchestration and distributed patient cohorts have inverted the traditional cost curve—and regulators are watching closely.

·6 min read